483
FUJIFILM Diosynth Biotechnologies UK LimitedFDA 483 - FUJIFILM Diosynth Biotechnologies UK Limited - March 17, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of FUJIFILM Diosynth Biotechnologies UK Limited in Billingham, United Kingdom, a drug substance manufacturer, revealed significant issues with process controls. The firm failed to prevent microbial contamination in multiple batches of drug substance and detected organisms of concern in its environmental monitoring program. This indicates a serious lapse in maintaining a sterile manufacturing environment.
Open in Dashboard
ID · b6518583-794c-4d2f-baec-63423c36352e